IT9047759A0 - Composizioni farmaceutiche contenenti 3-metiltiopropionil l-carnitina ad attivita' sul sistema cardiovascolare. - Google Patents

Composizioni farmaceutiche contenenti 3-metiltiopropionil l-carnitina ad attivita' sul sistema cardiovascolare.

Info

Publication number
IT9047759A0
IT9047759A0 IT9047759A IT4775990A IT9047759A0 IT 9047759 A0 IT9047759 A0 IT 9047759A0 IT 9047759 A IT9047759 A IT 9047759A IT 4775990 A IT4775990 A IT 4775990A IT 9047759 A0 IT9047759 A0 IT 9047759A0
Authority
IT
Italy
Prior art keywords
methylthiopropionyl
carnitine
activity
pharmaceutical compositions
compositions containing
Prior art date
Application number
IT9047759A
Other languages
English (en)
Other versions
IT9047759A1 (it
IT1240799B (it
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of IT9047759A0 publication Critical patent/IT9047759A0/it
Priority to IT47759A priority Critical patent/IT1240799B/it
Priority to DK91830083.1T priority patent/DK0448523T3/da
Priority to AT91830083T priority patent/ATE122561T1/de
Priority to DE69109721T priority patent/DE69109721T2/de
Priority to ES91830083T priority patent/ES2072591T3/es
Priority to EP91830083A priority patent/EP0448523B1/en
Priority to US07/669,573 priority patent/US5173508A/en
Priority to JP3049907A priority patent/JPH04217656A/ja
Publication of IT9047759A1 publication Critical patent/IT9047759A1/it
Application granted granted Critical
Publication of IT1240799B publication Critical patent/IT1240799B/it
Priority to HK98104739A priority patent/HK1005565A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT47759A 1990-03-15 1990-03-15 Composizioni farmaceutiche contenenti 3-metiltiopropionil l-carnitina ad attivita' sul sistema cardiovascolare. IT1240799B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IT47759A IT1240799B (it) 1990-03-15 1990-03-15 Composizioni farmaceutiche contenenti 3-metiltiopropionil l-carnitina ad attivita' sul sistema cardiovascolare.
ES91830083T ES2072591T3 (es) 1990-03-15 1991-03-11 Composiciones farmaceuticas activas sobre el sistema cardiovascular, que contienen 3-metiltiopropionil l-carnitina.
AT91830083T ATE122561T1 (de) 1990-03-15 1991-03-11 Pharmazeutische zubereitung mit wirkung auf das herzgefässsystem, die 3-methylthiopropionyl l- carnitin enthält.
DE69109721T DE69109721T2 (de) 1990-03-15 1991-03-11 Pharmazeutische Zubereitung mit Wirkung auf das Herzgefässsystem, die 3-Methylthiopropionyl L-Carnitin enthält.
DK91830083.1T DK0448523T3 (da) 1990-03-15 1991-03-11 Farmaceutiske præparater med virkning på det cardiovaskulære system, indeholdende 3-methylthiopropionyl-L-carnitin
EP91830083A EP0448523B1 (en) 1990-03-15 1991-03-11 Pharmaceutical compositions active on the cardiovascular system, containing 3-methylthiopropionyl L-carnitine
US07/669,573 US5173508A (en) 1990-03-15 1991-03-14 Pharmaceutical compositions active on the cardiovascular system, containing 3-methylthiopropionyl l-carnitine
JP3049907A JPH04217656A (ja) 1990-03-15 1991-03-14 ３−メチルチオプロピオニル−ｌ−カルニチンおよび医薬組成物
HK98104739A HK1005565A1 (en) 1990-03-15 1998-06-02 Pharmaceutical compositions active on the cardiovascular system containing 3- mehtylthiopropionyl l- carnitine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT47759A IT1240799B (it) 1990-03-15 1990-03-15 Composizioni farmaceutiche contenenti 3-metiltiopropionil l-carnitina ad attivita' sul sistema cardiovascolare.

Publications (3)

Publication Number Publication Date
IT9047759A0 true IT9047759A0 (it) 1990-03-15
IT9047759A1 IT9047759A1 (it) 1991-09-15
IT1240799B IT1240799B (it) 1993-12-17

Family

ID=11262331

Family Applications (1)

Application Number Title Priority Date Filing Date
IT47759A IT1240799B (it) 1990-03-15 1990-03-15 Composizioni farmaceutiche contenenti 3-metiltiopropionil l-carnitina ad attivita' sul sistema cardiovascolare.

Country Status (9)

Country Link
US (1) US5173508A (it)
EP (1) EP0448523B1 (it)
JP (1) JPH04217656A (it)
AT (1) ATE122561T1 (it)
DE (1) DE69109721T2 (it)
DK (1) DK0448523T3 (it)
ES (1) ES2072591T3 (it)
HK (1) HK1005565A1 (it)
IT (1) IT1240799B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US5863940A (en) 1997-12-01 1999-01-26 Sigma-Tau Healthscience S.P.A. Medicament and therapeutical method for treating idiopathic asthenozoospermia
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
DE69820029T3 (de) 1998-03-19 2011-05-19 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Kombinierte Zusammensetzung bestehend aus L-Karnitin oder L-Alkanoylkarnitin, einem Glycosaminoglycan und/oder einem seiner Bestandteile

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
IT1116037B (it) * 1979-04-23 1986-02-10 Sigma Tau Ind Farmaceuti Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico
IT1145371B (it) * 1980-05-30 1986-11-05 Sigma Tau Ind Farmaceuti Alcossi-acil carnitine procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
IT1170862B (it) * 1981-03-31 1987-06-03 Sigma Tau Ind Farmaceuti Mercaptoacil-carnitine procedimento per la loro preparazione e loro uso terapeutico
IT1177874B (it) * 1984-07-04 1987-08-26 Sigma Tau Ind Farmaceuti Estere della acetil carnitina,procedimenti per la sua preparazione e composizioni farmaceutiche che lo contengono

Also Published As

Publication number Publication date
DE69109721T2 (de) 1995-10-26
EP0448523A3 (en) 1992-04-15
EP0448523B1 (en) 1995-05-17
US5173508A (en) 1992-12-22
EP0448523A2 (en) 1991-09-25
IT9047759A1 (it) 1991-09-15
DK0448523T3 (da) 1995-06-06
JPH04217656A (ja) 1992-08-07
IT1240799B (it) 1993-12-17
ES2072591T3 (es) 1995-07-16
HK1005565A1 (en) 1999-01-15
DE69109721D1 (de) 1995-06-22
ATE122561T1 (de) 1995-06-15

Similar Documents

Publication Publication Date Title
ITRM910696A1 (it) Composizioni farmaceutiche per l'applicazione per via nasale.
FI915826A (fi) Farmaceutiska aemnen.
IT8919876A0 (it) Composizioni farmaceutiche agenti in particolare sul cuore e sul cuore e sul sistema cardiovascolare e procedimento per la loro preparazione.
DE3676671D1 (de) Askorbat-2-polyphosphatester und deren herstellung.
IT9019754A0 (it) Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica
IT8723183A0 (it) Composti attivi sul sistema cardiovascolare.
DE59106075D1 (de) 2-Methoximinocarbonsäureester.
IT9047759A0 (it) Composizioni farmaceutiche contenenti 3-metiltiopropionil l-carnitina ad attivita' sul sistema cardiovascolare.
IT8819838A0 (it) Composizioni farmaceutiche agenti sul cuore e sul sistema cardiovascolare e procedimento per la loro preparazione.
DE69101729D1 (de) Windmesser.
ITMI910380A0 (it) Composti steroidei attivi sul sistema cardiovascolare
IT8819791A0 (it) Peptidi ad attivita' farmaceutica.
IT8821544A0 (it) Composti attivi sul sistema cardiovascolare.
IT1248486B (it) Agente terapeutico ad attivita' sul sistema nervoso centrale
IT9047724A0 (it) Alfa-ammino-omega-alchiltioacilcarnitine e composizioni farmaceutiche contenenti tali composti ad attivita' sul sistema cardiovascolare.
IT1197297B (it) Composizioni farmaceutiche ad attivita' sul sistema nervoso centrale
ITMI912652A1 (it) Medicamento ad attivita' antielastasica.
IT8921544A0 (it) Composizioni farmaceutiche ad attivita' sul sistema nervoso centrale e periferico.
IT8723182A0 (it) Composti attivi sul sistema cardiovascolare.
IT8821545A0 (it) Composti attivi sul sistema cardiovascolare.
IT8821541A0 (it) Composti attivi sul sistema cardiovascolare.
IT8819790A0 (it) Peptidi ad attivita' farmaceutica.
FR2677788B1 (fr) Panneau d'affichage.
ITRM920045A0 (it) Composizioni farmaceutiche ad attivita' anti-aging.
FR2667779B1 (fr) Moniteur direct d'apn2e.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950131